Jazz Pharmaceuticals Investor Relations Material
Latest events
R&D Day 2024
Jazz Pharmaceuticals
Access the full event backlog
Slides, Transcripts, and Reports from 9,000+ public companies
Latest reports from Jazz Pharmaceuticals plc
Access all reports
Jazz Pharmaceuticals plc is a global specialty pharmaceutical company with a diversified portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement disorders; and in oncology, including hematologic and solid tumors. The company is developing an early stage pipeline focused on respiratory diseases and pain.
Key slides for Jazz Pharmaceuticals plc
Q4 2023
Jazz Pharmaceuticals plc
Q4 2023
Jazz Pharmaceuticals plc
Latest articles
The Three Cornerstones of Serial Acquirer Success
Explore what is behind successful serial acquirers: efficient capital use, decentralization, and a strong focus on people.
19 Apr 2024
Companies That Had Their IPO in 2023: Cautious Optimism
The cautiously optimistic market in 2023 saw stocks rebounded upwards, and interest in IPOs picked up from the previous year.
15 Apr 2024
Puig's 2024 IPO: Paco Rabanne, Jean Paul Gaultier, and Beyond
Explore Puig's journey from its 1914 inception to a 2024 IPO, showcasing its growth, strategic acquisitions, and impact in the beauty and fashion industry.
15 Apr 2024
Ticker symbol
Country
🇺🇸 United States